ASX - By Stock
|
RAP |
Re:
HOW TO VOTE
|
|
K1mval
|
123 |
36K |
3 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
123
|
36K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
HOW TO VOTE
|
|
K1mval
|
123 |
36K |
15 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
123
|
36K
|
15
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx
|
|
K1mval
|
126 |
37K |
1 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
126
|
37K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx
|
|
K1mval
|
126 |
37K |
30 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
126
|
37K
|
30
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp to present at Gold Coast Investment Showcase
|
|
K1mval
|
93 |
31K |
2 |
25/06/22 |
25/06/22 |
ASX - By Stock
|
93
|
31K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
K1mval
|
425 |
126K |
35 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
425
|
126K
|
35
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar
|
|
K1mval
|
118 |
37K |
18 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
118
|
37K
|
18
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
K1mval
|
377 |
143K |
15 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
377
|
143K
|
15
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Voluntary Suspension Extension
|
|
K1mval
|
92 |
43K |
9 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
92
|
43K
|
9
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
K1mval
|
3.3K |
2.5M |
22 |
12/06/22 |
12/06/22 |
ASX - By Stock
|
3.3K
|
2.5M
|
22
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Voluntary Suspension Extension
|
|
K1mval
|
92 |
43K |
10 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
92
|
43K
|
10
|
|
ASX - By Stock
|
RAP |
Re:
Vote NO Pfizer offer
|
|
K1mval
|
555 |
189K |
1 |
12/04/22 |
12/04/22 |
ASX - By Stock
|
555
|
189K
|
1
|
|